Clinical Trial Update: Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting: The PAPA CABG Study [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update reports completion of the study investigating preoperative aspirin and postoperative antiplatelet therapy in patients undergoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Coronary Artery Disease, Coronary Artery Bypass Grafting | Phase 3 | Status: COMPLETED